Welcome

On the “International Meeting on Retroviral Integration” researchers, basic scientists and clinicians come together to advance our knowledge on the integration of the retroviral DNA into the host chromatin. It blends the fields of chemistry, biology and clinical research in order to translate basic research into the clinic.

The 4th meeting in Siena, Italy, will cover all aspects of retroviral integration, spanning from biochemistry and structural biology to drug discovery and the clinics of integrase inhibitors.

A mini symposium will highlight the role of retroviral integration in gene therapy and will bring leading scientists in this field together to discuss advances in gene therapy.

We especially welcome young scientist and newcomers to the field to join the meeting.

A limited number of travel grants is available for postdoc and students presenting a poster on this meeting. Please submit a letter of recommendation together with your abstract for travel grant applications.

Confirmed speakers

Gloria Arriagada, New York, USA
Maurizio Botta, Siena, It
Rick Bushman, Philadelphia, PA, USA
Barbara Capecchi, Novartis, Italy
Francesca Ceccherini-Silberstein, Roma, It
Anna Cereseto, Trento, It
Peter Cherepanov, London, UK
Bob Craigie, Bethesda, MD, USA
Zeger Debyser, Leuven, Be
Ira Dicker, Bristol-Myers Squibb, USA
Alan Engelman, Boston, MA, USA
Romas Geleziunas, Gilead Sciences, USA
Mauro Giacca, Trieste, It
Duane Grandgenett, St. Louis, MO, USA
Daria Hazuda, Merck, USA
Thomas Hope, Chicago, USA
Zoltán Ivics, Berlin, De
Mamuka Kvaratskhelia, Columbus, USA
Louie Lamorte, Boehringer Ingelheim, Canada
Henry Levin, Bethesda, USA
Fulvio Mavilio, Milan, It
Sherwin Montano, Chicago, USA
Luigi Naldini, Milan, It
Nouri Neamati, Los Angeles, USA
Chris Pickford, Pfizer, UK
Eric Poeschla, Rochester, USA
Yves Pommier, Bethesda, USA
Suzanne Sandmeyer, Irvine, USA
Mark Underwood, GlaxoSmithKline, USA
Christof Von Kalle, Heidelberg, De
Mark Wainberg, Montreal, Ca